ZA953841B - P75 TNF receptor promoters - Google Patents

P75 TNF receptor promoters

Info

Publication number
ZA953841B
ZA953841B ZA953841A ZA953841A ZA953841B ZA 953841 B ZA953841 B ZA 953841B ZA 953841 A ZA953841 A ZA 953841A ZA 953841 A ZA953841 A ZA 953841A ZA 953841 B ZA953841 B ZA 953841B
Authority
ZA
South Africa
Prior art keywords
tnf receptor
receptor promoters
promoters
sequence
upstream
Prior art date
Application number
ZA953841A
Other languages
English (en)
Inventor
David Wallach
Peter Kuhnert
Gotz Ehrhardt
Oliver Kemper
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA953841B publication Critical patent/ZA953841B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA953841A 1994-05-11 1995-05-11 P75 TNF receptor promoters ZA953841B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter

Publications (1)

Publication Number Publication Date
ZA953841B true ZA953841B (en) 1996-01-17

Family

ID=11066126

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953841A ZA953841B (en) 1994-05-11 1995-05-11 P75 TNF receptor promoters

Country Status (13)

Country Link
EP (1) EP0759759B1 (fr)
JP (1) JP3663211B2 (fr)
AT (1) ATE254173T1 (fr)
AU (1) AU699280B2 (fr)
CA (1) CA2189984C (fr)
CY (1) CY2524B1 (fr)
DE (1) DE69532115T2 (fr)
DK (1) DK0759759T3 (fr)
ES (1) ES2206505T3 (fr)
IL (1) IL109633A (fr)
PT (1) PT759759E (fr)
WO (1) WO1995031206A1 (fr)
ZA (1) ZA953841B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
WO2014046247A1 (fr) * 2012-09-20 2014-03-27 東亞合成株式会社 Peptide synthétique pour l'ajustement de l'équilibre des récepteurs tnf de type 1 et des récepteurs tnf de type 2, et utilisation dudit peptide

Also Published As

Publication number Publication date
AU2546895A (en) 1995-12-05
DE69532115D1 (de) 2003-12-18
IL109633A (en) 2005-05-17
CA2189984C (fr) 2008-03-25
PT759759E (pt) 2004-01-30
EP0759759A1 (fr) 1997-03-05
CY2524B1 (en) 2006-02-08
JP3663211B2 (ja) 2005-06-22
AU699280B2 (en) 1998-11-26
JPH10500304A (ja) 1998-01-13
EP0759759B1 (fr) 2003-11-12
IL109633A0 (en) 1994-08-26
ES2206505T3 (es) 2004-05-16
EP0759759A4 (fr) 1997-11-26
CA2189984A1 (fr) 1995-11-23
DE69532115T2 (de) 2004-08-26
DK0759759T3 (da) 2004-02-02
WO1995031206A1 (fr) 1995-11-23
ATE254173T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
EP0675225A3 (fr) Papier de soie doux mono-couche ayant une asymétrie cÔté toile/cÔté fentre très faible.
WO1992013950A3 (fr) SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
EP1007537A4 (fr) Proteine receptrice designee par 2f1
WO1994005791A3 (fr) Facteur influant sur la croissance du tissu dorsal et compositions
BG103169A (en) Ligand related to tumour necrotic factor
ZA979619B (en) Nozzle.
EP0676156A4 (fr) Chaise combinee.
AU3745795A (en) Use of CCK-B receptor antagonists for the treatment of sleepdisorders
CY2524B1 (en) P75 tnf receptor promoters
ZA97559B (en) Dihalopropene compounds, their use and intermediates for their production.
WO1997012963A3 (fr) Paf-acetylhydrolase paf et son utilisation en therapie
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
MY106522A (en) Arylaminocarbonyl compounds.
AU3003095A (en) Proteins associated with tumor necrosis factor receptor
AU1067697A (en) Hsd17b1 promoter, enhancer, silencer and use thereof
AU7427194A (en) Control mechanism for the seat carriers of chairs, especially swivel chairs
ZA966489B (en) New protein human MP52 Arg.
AU5115598A (en) Novel pentaerythritol derivatives, preparation and use thereof and intermediates for the synthesis thereof
EP0584365A4 (fr) Nouvel agent favorisant la repousse et la croissance des cheveux.
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
AU6676796A (en) Compounds, compositions, and methods for inhibiting replication of retroviruses and for inhibiting tumor promoter initiated transcription
GB2325466A (en) Nucleotide sequence from goat liver